Autolus Therapeutics announced the appointment of Matthias Will, M.D., as Chief Development Officer. Dr. Will is joining Autolus’ executive team and will lead the company’s development organization effective September 30, 2024. Will joins Autolus from Dren Bio, where he served as Chief Medical Officer
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AUTL:
- Autolus presents clinical data on TB-guided dosing strategy at SOHO meetin
- Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024
- Autolus Therapeutics Q2 Results and Corporate Presentation Update
- Autolus Therapeutics reports Q2 EPS (22c), consensus (19c)
- Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates